Your browser doesn't support javascript.
loading
Switching maintenance infliximab therapy to biosimilar infliximab in inflammatory bowel disease patients.
Eberl, Anja; Huoponen, Saara; Pahikkala, Tapio; Blom, Marja; Arkkila, Perttu; Sipponen, Taina.
Afiliação
  • Eberl A; a Department of Gastroenterology , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
  • Huoponen S; b Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy , University of Helsinki , Helsinki , Finland.
  • Pahikkala T; c Department of Future Technologies , University of Turku , Turku , Finland.
  • Blom M; b Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy , University of Helsinki , Helsinki , Finland.
  • Arkkila P; a Department of Gastroenterology , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
  • Sipponen T; a Department of Gastroenterology , Helsinki University Hospital, University of Helsinki , Helsinki , Finland.
Scand J Gastroenterol ; 52(12): 1348-1353, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28838273
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Infliximab / Anticorpos Monoclonais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Infliximab / Anticorpos Monoclonais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article